Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.14
-0.3300-2.45%
Volume:530.87K
Turnover:6.92M
Market Cap:73.46M
PE:-1.69
High:13.65
Open:13.53
Low:12.35
Close:13.47
Loading ...

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire
·
14 Nov 2024

Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801

TIPRANKS
·
13 Nov 2024

BRIEF-Tonix Pharmaceuticals Announces Peer-Reviewed Publication In Msphere Journal Highlighting The Tolerability Of Company’S Single-Dose Mpox And Smallpox Vaccine Candidate TNX-801, In Immune-Compromised Animals

Reuters
·
13 Nov 2024

Tonix Pharmaceuticals Holding Corp - Tnx-801 Tolerability in Immune-Compromised Animals Supports Clinical Development

THOMSON REUTERS
·
13 Nov 2024

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Msphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate Tnx-801, in Immune-Compromised Animals

THOMSON REUTERS
·
13 Nov 2024

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

GlobeNewswire
·
13 Nov 2024

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

Tonix Pharmaceuticals Q3 2024 GAAP EPS $(0.23) Beats $(2.93) Estimate, Sales $2.80M Miss $3.08M Estimate

Benzinga
·
12 Nov 2024

Tonix Pharmaceuticals reports Q3 EPS (23c), consensus ($2.93)

TIPRANKS
·
12 Nov 2024

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire
·
12 Nov 2024

Tonix Pharmaceuticals Holding Corp expected to post a loss of $2.93 a share - Earnings Preview

Reuters
·
06 Nov 2024

Tonix Pharma Partners for Vaccine Clinical Trial

TipRanks
·
05 Nov 2024

BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya

Reuters
·
04 Nov 2024

Tonix Pharmaceuticals announces research agreement with KEMRI

TIPRANKS
·
04 Nov 2024

Tonix Pharmaceuticals Holding Corp - to Sponsor, Kemri to Lead Clinical Trial for Tnx-801

THOMSON REUTERS
·
04 Nov 2024

Tonix Pharmaceuticals Holding Corp - to Test Tnx-801 Vaccine for Mpox in Kenya

THOMSON REUTERS
·
04 Nov 2024